Growth Metrics

Vanda Pharmaceuticals (VNDA) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14.19%
Dec 31, 2025 -29.79%
Sep 30, 2025 -4.18%
Jun 30, 2025 -4.91%
Mar 31, 2025 -5.04%
Dec 31, 2024 -0.49%
Sep 30, 2024 -0.24%
Jun 30, 2024 -0.27%
Mar 31, 2024 -0.17%
Dec 31, 2023 0.33%
Sep 30, 2023 0.59%
Jun 30, 2023 0.78%
Mar 31, 2023 1.62%
Dec 31, 2022 2.24%
Sep 30, 2022 1.40%
Jun 30, 2022 1.28%
Mar 31, 2022 -0.56%
Dec 31, 2021 2.35%
Sep 30, 2021 2.51%
Jun 30, 2021 2.91%
Mar 31, 2021 3.17%
Dec 31, 2020 2.88%
Sep 30, 2020 2.08%
Jun 30, 2020 3.65%
Mar 31, 2020 1.32%
Dec 31, 2019 2.50%
Sep 30, 2019 35.12%
Jun 30, 2019 6.57%
Mar 31, 2019 1.08%
Dec 31, 2018 5.36%
Sep 30, 2018 4.04%
Jun 30, 2018 4.20%
Mar 31, 2018 83.54%
Dec 31, 2017 0.70%
Sep 30, 2017 -0.72%
Jun 30, 2017 2.56%
Mar 31, 2017 -2.43%
Dec 31, 2016 1.68%
Sep 30, 2016 6.21%
Jun 30, 2016 -1.14%
Mar 31, 2016 -7.53%
Dec 31, 2015 -8.85%
Sep 30, 2015 -2.54%
Jun 30, 2015 -1.79%
Mar 31, 2015 -5.19%
Dec 31, 2014 15,028.60%
Sep 30, 2014 20.11%
Jun 30, 2014 -95.78%
Mar 31, 2014 -52.45%
Dec 31, 2013 -11.76%
Sep 30, 2013 894.87%
Jun 30, 2013 -22.45%
Mar 31, 2013 -34.57%
Dec 31, 2012 -35.48%
Sep 30, 2012 -23.56%
Jun 30, 2012 -25.39%
Mar 31, 2012 -19.58%
Dec 31, 2011 -11.17%
Sep 30, 2011 -4.69%